CARDIOL THERAPEUTICS
Cardiol Therapeutics focuses on producing pharmaceutical cannabidiol products and developing innovative therapies for heart disease, including acute myocarditis and other causes of heart failure. Cardiol Therapeutics leverages their expertise in pharmaceutical cannabinoids to develop proprietary formulations for commercial development in two important medical markets: commercializing a line of pharmaceutical cannabidiol products in the growing market for medical cannabinoids and developing nanotechnologies designed to deliver cannabinoids and other anti-inflammatory drugs to the heart for the treatment of inflammatory heart disease.
CARDIOL THERAPEUTICS
Industry:
Biotechnology Life Science Nanotechnology
Founded:
2017-01-01
Address:
Oakville, Ontario, Canada
Country:
Canada
Website Url:
http://www.cardiolrx.com
Total Employee:
11+
Status:
Active
Contact:
289.910.0850
Email Addresses:
[email protected]
Total Funding:
76.27 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Content Delivery Network Google Universal Analytics
Similar Organizations
Akebia Therapeutics
Akebia Therapeutics develops treatments for ischemia and vascular diseases.
Autobahn Therapeutics
Autobahn Therapeutics is a developer of regenerative medicines to restore hope for people affected by CNS disorders.
ImmPACT Bio
ImmPACT Bio USA is developing novel cell therapies for treating cancer.
Voyager Therapeutics
Voyager Therapeutics is a gene therapy company developing treatments for fatal and debilitating diseases of the central nervous system
Werewolf Therapeutics
Werewolf Therapeutics operates as an oncology biotherapeutics company.
Current Employees Featured
Founder
Stock Details
Investors List
Raymond James
Raymond James investment in Post-IPO Equity - Cardiol Therapeutics
Canaccord Genuity Group
Canaccord Genuity Group investment in Post-IPO Equity - Cardiol Therapeutics
AlbaCore Capital
AlbaCore Capital investment in Post-IPO Equity - Cardiol Therapeutics
Echelon Wealth Partners
Echelon Wealth Partners investment in Post-IPO Equity - Cardiol Therapeutics
Official Site Inspections
http://www.cardiolrx.com Semrush global rank: 7.26 M Semrush visits lastest month: 548
- Host name: 65.39.134.189
- IP address: 65.39.134.189
- Location: Toronto Canada
- Latitude: 43.6683
- Longitude: -79.4205
- Timezone: America/Toronto
- Postal: M6G